国家: 爱尔兰
语言: 英文
来源: HPRA (Health Products Regulatory Authority)
Posaconazole
McDermott Laboratories Ltd., T/A Gerard Laboratories
J02AC; J02AC04
Posaconazole
100 milligram(s)
Gastro-resistant tablet
Triazole derivatives; posaconazole
Marketed
2019-12-06
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT POSACONAZOLE MYLAN 100 MG GASTRO-RESISTANT TABLETS posaconazole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist, or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Posaconazole Mylan is and what it is used for 2. What you need to know before you take Posaconazole Mylan 3. How to take Posaconazole Mylan 4. Possible side effects 5. How to store Posaconazole Mylan 6. Contents of the pack and other information 1. WHAT POSACONAZOLE MYLAN IS AND WHAT IT IS USED FOR Posaconazole Mylan contains the active substance posaconazole. This belongs to a group of medicines called “antifungals”. It is used to prevent and treat many different fungal infections. This medicine works by killing or stopping the growth of some types of fungi that can cause infections. Posaconazole Mylan can be used in adults to treat fungal infections caused by fungi of the _Aspergillus _ family Posaconazole Mylan can be used in adults and children from 2 years of age weighing more than 40 kg to treat the following types of fungal infections: • infections caused by fungi of the _Aspergillus _ family that have not improved during treatment with the anti-fungal medicines amphotericin B or itraconazole or when these medicines have had to be stopped; • infections caused by fungi of the _Fusarium _ family that have not improved during treatment with amphotericin B or when amphotericin B has had to be stopped; • infections caused by fungi that cause the conditions known as “chromoblastomycosis” and “mycetoma” that 阅读完整的文件
HealthProductsRegulatoryAuthority 29November2023 CRN00D0YZ Page1of19 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT PosaconazoleMylan100mggastro-resistanttablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Eachgastro-resistanttabletcontains100mgofposaconazole. Forthefulllistofexcipients,seesection6.1. 3 PHARMACEUTICAL FORM Gastro-resistanttablet Yellowcoated,capsuleshapedtabletofapproximately17.5mmlengthand6.7mmwidth,debossedwith"100P"ononeside andplainontheotherside. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS PosaconazoleMylanisindicatedforuseinthetreatmentofthefollowingfungalinfectionsinadults(seesection4.2and5.1): Invasiveaspergillosis PosaconazoleMylanisindicatedforuseinthetreatmentofthefollowingfungalinfectionsinpaediatricpatientsfrom2years ofageweighingmorethan40kgandadults(seesections4.2and5.1): InvasiveaspergillosisinpatientswithdiseasethatisrefractorytoamphotericinBoritraconazoleorinpatientswho areintolerantofthesemedicinalproducts; FusariosisinpatientswithdiseasethatisrefractorytoamphotericinBorinpatientswhoareintolerantof amphotericinB; Chromoblastomycosisandmycetomainpatientswithdiseasethatisrefractorytoitraconazoleorinpatientswho areintolerantofitraconazole; CoccidioidomycosisinpatientswithdiseasethatisrefractorytoamphotericinB,itraconazoleorfluconazoleorin patientswhoareintolerantofthesemedicinalproducts. Refractorinessisdefinedasprogressionofinfectionorfailure 阅读完整的文件